(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
95%
- Product Code: 237555
CAS:
1644461-85-7
| Molecular Weight: | 538.570 g./mol | Molecular Formula: | C₂₃H₂₈F₂N₆O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used as a potent inhibitor of the sodium-glucose co-transporter 2 (SGLT2) in the treatment of type 2 diabetes. It helps lower blood glucose levels by promoting the excretion of excess glucose through urine. Due to its high selectivity for SGLT2, it minimizes the risk of off-target effects, making it suitable for long-term management of hyperglycemia. It also contributes to modest reductions in body weight and blood pressure, offering additional benefits in diabetic patients. The compound is typically administered orally and shows good bioavailability and metabolic stability. Its sulfinyl group enhances binding affinity and pharmacokinetic profile, supporting once-daily dosing in clinical settings.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿38,000.00 |
+
-
|
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Used as a potent inhibitor of the sodium-glucose co-transporter 2 (SGLT2) in the treatment of type 2 diabetes. It helps lower blood glucose levels by promoting the excretion of excess glucose through urine. Due to its high selectivity for SGLT2, it minimizes the risk of off-target effects, making it suitable for long-term management of hyperglycemia. It also contributes to modest reductions in body weight and blood pressure, offering additional benefits in diabetic patients. The compound is typically administered orally and shows good bioavailability and metabolic stability. Its sulfinyl group enhances binding affinity and pharmacokinetic profile, supporting once-daily dosing in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :